IDEAYA Biosciences
Highly Engaged Employees
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5000 Shoreline Ct Ste 300, South San Fra...Phone Number
(650) 443-6209Website
www.ideayabio.comRevenue
$234.1 MillionStock Symbol
IDYAIndustry
About IDEAYA Biosciences
IDEAYA Biosciences Org Chart
Is IDEAYA Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if IDEAYA Biosciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on IDEAYA Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once IDEAYA Biosciences has new funding data
Click to see if IDEAYA Biosciences had a recent Job posting/layoffs
IDEAYA Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if IDEAYA Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at IDEAYA Biosciences
Product Launch: Get notified when IDEAYA Biosciences launches new products
Recommended Actions
Reach out to Masked Content who joined IDEAYA Biosciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to IDEAYA Biosciences
Compare insights from companies similar to IDEAYA Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IDEAYA Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IDEAYA Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IDEAYA Biosciences.
IDEAYA Biosciences Tech Stack
A closer look at the technologies used by IDEAYA Biosciences
Most Recent Scoops
IDEAYA Biosciences News & Media
IDEAYA Biosciences, Inc. (IDYA) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
IDEAYA Biosciences, Inc. (IDYA) Citigroup's Biopharma Back to School Summit 2026 September 10, 2026 1:40 PM EDTCompany ParticipantsYujiro Hata - Founder,...IDEAYA Biosciences and Servier Announce First Patient Dosed in OptimUM-11 Global Phase 3 Registrational Trial of Darovasertib and Crizotinib as Adjuvant Therapy for Subjects with Uveal Melanoma
Global Phase 3 trial will evaluate the darovasertib and crizotinib combination in primary uveal melanoma patients with increased risk of metastasis following completion of local therapy OptimUM-11 expands development of darovasertib across the uveal melanoma patient journey into the...IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 1, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced its upcoming Investor R&D Day in London and participation in...IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer
Based on FDA Type C meeting, targeting to initiate a randomized Phase 3 registrational trial for IDE849 monotherapy by year-end 2026 in ES-SCLC, with ORR by BICR as the primary endpoint for potential accelerated approval and median OS as the primary endpoint for potential full approval...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IDEAYA Biosciences
Ideaya Biosciences is a biotechnology company dedicated to the discovery and development of therapeutics for patient populations using molecular diagnostics. The company was founded in 2015 and is headquartered in South San Francisco, California.... Read More